AF-219,
Gefapixant,
AF-219,
1015787-98-0,
MK-7264,
UNII-6K6L7E3F1L,
6K6L7E3F1L,
C14H19N5O4S,
5-[2,4-bis(azanyl)pyrimidin-5-yl]oxy-2-methoxy-4-propan-2-yl-benzenesulfonamide,
Benzenesulfonamide, 5-((2,4-diamino-5-pyrimidinyl)oxy)-2-methoxy-4-(1-methylethyl)-,
Benzenesulfonamide, 5-[(2,4-diamino-5-pyrimidinyl)oxy]-2-methoxy-4-(1-methylethyl)-,
Gefapixant [USAN],
GTPL9540,
SCHEMBL1493905,
CHEMBL3716057,
HLWURFKMDLAKOD-UHFFFAOYSA-N,
AF219,
BCP26079,
ZINC116342482,
RG-1646,
AF-219; MK-7264,
Ro-4926219,
HY-101588,
RO4926219,
CS-0021727,
RO 4926219,
J3.556.891C,
R-1646,
2-Methoxy-4-isopropyl-5-(2,4-diamino-5-pyrimidinyloxy)benzenesulfonamide,
5-((2,4-diaminopyrimidin-5-yl)oxy)-4-isopropyl-2-methoxybenzenesulfonamide,
5-(2,4-diamino-pyrimidin-5-yloxy)-4-isopropyl-2-methoxy-benzenesulfonamide,
5-(2,4-diaminopyrimidin-5-yl)oxy-2-methoxy-4-propan-2-ylbenzenesulfonamide,
5-((2,4-Diaminopyrimidin-5-yl)oxy)-2-methoxy-4-(propan-2-yl)benzenesulfonamide,
5-[(2,4-diaminopyrimidin-5-yl)oxy]-2-methoxy-4-(propan-2-yl)benzene-1-sulfonamide,
AF9,